Cindy Wilson

Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas

Cindy Wilson, Lillian Ramos, Maria R. Villaseñor et al. · Nature Genetics · 1999 · 416 citations

Tumor Biology, Breast Oncology, Medicine +9

Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitro

Richard S. Finn, Judy Dering, Charles Ginther et al. · Breast Cancer Research and Treatment · 2007 · 400 citations · Full text

Breast Oncology, Pathology, Cancer Biology +17

Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-Δ11b

Cindy Wilson, Marc Payton, Gary Elliott et al. · Oncogene · 1997 · 194 citations

Biological Toxicity, Medicine, Differential Subcellular Localization +7

Discovery of Novel, Induced-Pocket Binding Oxazolidinones as Potent, Selective, and Orally Bioavailable Tankyrase Inhibitors

Howard Bregman, Nagasree Chakka, Angel Guzmán-Pérez et al. · Journal of Medicinal Chemistry · 2013 · 76 citations · Full text

Drug Target, Selective Tankyrase Inhibitors, Pharmacotherapy +20

HER-2 overexpression differentially alters transforming growth factor-β responses in luminal versus mesenchymal human breast cancer cells

Cindy Wilson, Elaina Cajulis, Jennifer L. Green et al. · Breast Cancer Research · 2005 · 53 citations · Full text